Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSigma Healthcare Ltd

Sigma Healthcare Ltd

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
2.82 AUD 0.00(0%)
Last update at 2026-11-06T05:40:00Z
VOLUME
109724634
Market Cap
32553.24M
P/E
47.00

Momentum Score

…

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.81
Low
2.85
High
52 Week Price Range
2.47
Low
3.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Sigma Healthcare is an Australian pharmaceutical wholesaler and distributor serving community pharmacies, hospitals and healthcare providers, with support services for independent retailers in Australia and New Zealand. Long-term growth may be driven by aging-related medicine demand, expanded services for independents, and logistics and e-commerce opportunities, giving recurring revenue and scale benefits.

Key risks are intense competition from larger distributors and pharmacy chains, margin exposure to PBS and regulatory change, customer concentration and execution risk on strategic initiatives.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.82
Dividend Yield
1.43%
Revenue TTM
10834.97M
Revenue Per Share
0.94
Gross Profit TTM
1956.87M
Debt / Equity
0.40
ROE
14.69%
Net Debt
1889.42M
ROCE
13.69%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Income before tax 1005.07M 11.15M 8.62M 5.46M -8.31M
Minority interest - -0.92M -0.80M -1.22M -0.90M
Net income 709.18M -13.84M 4.51M 3.03M -6.34M
Selling general administrative - 117.69M 88.62M 82.62M 93.02M
Selling and marketing expenses - 333.66M 173.15M 210.38M 216.58M
Gross profit 1956.87M 334.05M 189.82M 320.63M 296.51M
Reconciled depreciation - 25.81M 28.32M 30.34M 27.69M
Ebit 997.97M 29.66M 24.93M 26.86M 4.18M
Ebitda 1083.00M 55.47M 53.25M 57.19M 31.87M
Depreciation and amortization 85.03M 25.81M 28.32M 30.34M 27.69M
Operating income 997.97M -10.08M -71.95M 26.86M 4.18M
Other operating expenses 9837.00M 4904.02M 3394.01M 3735.65M 3556.35M
Interest expense 114.22M 18.51M 16.30M 14.41M 10.84M
Tax provision - 24.06M 3.31M 2.44M -1.97M
Interest income - 8.00M 1.72M 0.60M 0.22M
Net interest income - -10.51M -14.58M -13.81M -10.62M
Income tax expense 296.42M 24.06M 3.31M 2.44M -1.97M
Total revenue 10834.97M 4893.94M 3322.06M 3726.46M 3515.56M
Total operating expenses 958.90M 344.13M 261.77M 329.82M 337.29M
Cost of revenue 8878.10M 4559.88M 3132.24M 3405.83M 3219.06M
Total other income expense net 7.11M 21.23M -83.13M -21.40M -12.49M
Net income from continuing ops - -12.92M 5.31M 3.03M -6.34M
Net income applicable to common shares - -13.84M 4.51M 1.81M -7.24M
Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Total assets 9337.93M 1830.57M 1404.13M 1174.07M 1248.28M
Intangible assets 225.23M 19.65M 20.00M 22.90M 25.09M
Other current assets 43.00M 26.06M 14.91M 11.87M 50.17M
Total liab 4348.43M 991.29M 531.52M 696.31M 759.50M
Total stockholder equity 4995.69M 837.86M 870.77M 475.92M 487.19M
Other current liab 542.36M 126.77M 57.99M 57.45M 77.76M
Common stock 4391.57M 1641.07M 1682.37M 1234.46M 1225.45M
Capital stock - 1641.07M 1637.02M 1234.46M 1225.45M
Retained earnings 538.29M -799.53M -769.18M -761.59M -741.13M
Other liab - - - 4.91M 4.15M
Good will 3626.11M 89.06M 89.06M 95.22M 102.96M
Other assets - - - 61.68M 59.40M
Cash 131.12M 14.57M 356.50M 16.65M 31.14M
Total current liabilities 2050.17M 864.97M 371.28M 477.36M 457.61M
Current deferred revenue - 1.17M 0.14M 0.96M 1.89M
Net debt 1889.42M 117.51M -219.87M 210.34M 292.29M
Short term debt 207.85M 10.64M 9.79M 12.94M 25.69M
Short long term debt - - - 3.68M 15.38M
Short long term debt total 2020.55M 132.09M 136.63M 226.99M 323.43M
Other stockholder equity - - -45.35M 0.22M 2.87M
Property plant equipment - - - 290.92M 281.56M
Total current assets 3426.48M 1376.79M 912.50M 685.85M 761.63M
Long term investments - 8.52M 13.62M 16.08M 17.63M
Net tangible assets - - - 357.68M 359.14M
Short term investments - - - 0.00M 0.01M
Net receivables 2006.54M 952.72M 319.96M 332.48M 358.68M
Long term debt - - - 80.00M 165.00M
Inventory 1245.82M 383.44M 221.13M 324.85M 321.64M
Accounts payable 1299.96M 726.38M 303.36M 406.01M 352.27M
Accumulated other comprehensive income 65.84M -3.68M 2.92M 3.04M 2.87M
Non currrent assets other 17.51M 38.73M 1.19M 1.31M 0.78M
Non current assets total 5911.45M 453.78M 491.63M 488.23M 486.65M
Capital lease obligations - 132.09M 136.63M 143.30M 143.06M
Long term debt total - - - 214.04M 297.74M
Breakdown 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Type yearly yearly yearly yearly yearly
Date 2026-01-31 2025-01-31 2024-01-31 2023-01-31 2022-01-31
Investments - -1.60M 5.73M -28.60M -2.39M
Change to liabilities - - - 53.54M -7.11M
Total cashflows from investing activities 61.69M -1.60M 5.73M -28.60M -16.59M
Net borrowings - 323.89M -80.00M -101.88M 148.62M
Total cash from financing activities -645.19M -24.73M 295.82M -116.94M 128.89M
Change to operating activities - - - 16.64M -51.52M
Net income 709.18M -13.84M 4.51M 3.03M -7.24M
Change in cash -7.65M -341.92M 343.53M -2.80M 66.02M
Begin period cash flow 138.77M 356.50M 12.97M 15.77M -50.25M
End period cash flow 131.12M 14.57M 356.50M 12.97M 15.77M
Total cash from operating activities 575.56M -315.59M 41.97M 33.36M 27.69M
Issuance of capital stock - 2.68M 396.12M 0.88M 0.20M
Depreciation 85.03M - 28.32M 30.34M 27.69M
Other cashflows from investing activities 142.87M -151.61M 8.93M 0.80M -0.00M
Dividends paid 378.81M -17.13M -9.98M 15.94M 19.93M
Change to inventory -217.31M -57.26M 103.72M -3.21M 27.50M
Change to account receivables -284.12M -103.75M 10.88M 27.50M -30.73M
Sale purchase of stock - 2.68M -9.50M 0.88M 0.20M
Other cashflows from financing activities -160.39M -334.17M -10.31M -16.88M 148.62M
Change to netincome - - - 23.43M 9.39M
Capital expenditures 56.73M 7.91M 4.72M 29.40M 14.20M
Change in working capital -192.04M -336.17M 16.29M 0.60M 0.22M
Stock based compensation - - 2.75M - -
Other non cash items -26.62M 20.58M -2.65M -33.36M -20.45M
Free cash flow 518.83M -323.50M 37.25M 3.96M 13.49M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SIG
Sigma Healthcare Ltd		 -
-%		 2.82 47.00 32.15 3.00 6.45 3.15 30.00
EBO
Ebos Group Ltd		 -0.11
0.63%		 17.29 15.13 18.08 0.27 1.34 0.39 9.21
PGC
Paragon Care Ltd		 -0.01
3.23%		 0.15 - 5.98 0.07 0.84 0.17 13.27
MYX
Mayne Pharma Group Ltd		 0.37
13.65%		 3.08 8.74 263.16 0.58 0.55 0.47 1.28

Profile*

Sigma Healthcare Ltd

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.

6 Albert Street, Preston, VIC, Australia, 3072

61 3 9215 9215

https://sigmahealthcare.com.au

Name Title Year Born
Mr. Vikesh Ramsunder B.Com. CEO, MD & Director 1971
Mr. Nigel Simonsz Chief Financial Officer NA
Mr. Martin Hawkins Chief Information Officer NA
Ms. Kara McGowan Company Sec. & Gen. Counsel NA
Mr. Mark Conway B.Com., M.B.A. Chief Financial Officer NA
Ms. Kara McGowan A.C.I.S., L.L.B. Company Secretary & General Counsel NA
Mr. Gary Woodford Head of Corporate Affairs NA
Mr. Mark Conway B.Com., M.B.A. Chief Financial Officer NA
Ms. Kara McGowan A.C.I.S., L.L.B. Company Secretary & General Counsel NA
Mr. Gary Woodford Head of Corporate Affairs NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…